UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma

Natural product research, 2018-09, Vol.32 (18), p.2217-2220

2018

Volltextzugriff (PDF)

Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma

Critical reviews in oncology/hematology, 2024-04, Vol.196, p.104312-104312, Article 104312

2024

Volltextzugriff (PDF)

MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions

Non-coding RNA research, 2020-03, Vol.5 (1), p.11-21

2020

Volltextzugriff (PDF)

miR-17–5p/STAT3/H19: A novel regulatory axis tuning ULBP2 expression in young breast cancer patients

Pathology, research and practice, 2024-11, Vol.263, p.155638, Article 155638

2024

Volltextzugriff (PDF)

Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies

Pathology, research and practice, 2024-04, Vol.256, p.155223-155223, Article 155223

2024

Volltextzugriff (PDF)

miR-4317, a promising player tuning the anti-tumor armamentarium against breast cancer

Annals of oncology, 2018-09, Vol.29, p.vi18-vi19

2018

Volltextzugriff (PDF)

Structural diversity of the cardenolide calotropin renders it as a targeted therapy for harnessing TNBC progression through tuning nitric oxide (NO) levels

Annals of oncology, 2019-02, Vol.30 Suppl 1, p.i14

2019

Volltextzugriff (PDF)

Mir-506-3p synergistically represses breast cancer progression through altering cell cycle regulators

Annals of oncology, 2018-09, Vol.29, p.vi28-vi28

2018

Volltextzugriff (PDF)

Regulating rs2278414 (G/A) disease-associated SNP in ZNF350 3’UTR by miR-150-5p: A step towards personalised therapy in breast cancer

Annals of oncology, 2018-09, Vol.29, p.vi22-vi22

2018

Volltextzugriff (PDF)

A novel acetylated derivative of vitexin improves the immunogenic profile of breast cancer through tuning miR-20a/MICA Axis

Annals of oncology, 2018-09, Vol.29, p.vi18-vi18

2018

Volltextzugriff (PDF)

Crosstalk between hesperetin and miR-486-5p in triple-negative breast cancer (TNBC): An approach towards precision medicine

Annals of oncology, 2018-09, Vol.29, p.vi28-vi29

2018

Volltextzugriff (PDF)

Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155

Growth factors (Chur, Switzerland), 2017-05, Vol.35 (2-3), p.49-60

2017

Volltextzugriff (PDF)

23PA new quercetin glycoside enhances TNBC immunological profile through TP53/miR-155/MICA/ULBP2

Annals of oncology, 2019-11, Vol.30 (Supplement_7)

2019

Volltextzugriff (PDF)

1897PInterplay between miR-17-5p and MALAT-1 shapes the cytokine storm in triple negative breast cancer (TNBC) tumor microenvironment

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

36PStructural diversity of the cardenolide calotropin renders it as a targeted therapy for harnessing TNBC progression through tuning nitric oxide (NO) levels

Annals of oncology, 2019-02, Vol.30 (Supplement_1)

2019

Volltextzugriff (PDF)